Adjuvant endocrine therapy in hormone receptor-positive postmenopausal breast cancer: evolution of NCCN, ASCO, and St Gallen recommendations (Q36656547)

From Wikidata
Jump to navigation Jump to search
scientific article published on November 2006
edit
Language Label Description Also known as
English
Adjuvant endocrine therapy in hormone receptor-positive postmenopausal breast cancer: evolution of NCCN, ASCO, and St Gallen recommendations
scientific article published on November 2006

    Statements

    Adjuvant endocrine therapy in hormone receptor-positive postmenopausal breast cancer: evolution of NCCN, ASCO, and St Gallen recommendations (English)
    Robert W Carlson
    Clifford A Hudis
    Kathy I Pritchard
    National Comprehensive Cancer Network Breast Cancer Clinical Practice Guidelines in Oncology
    American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors
    St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer
    1 November 2006
    971-979

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit